EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 91, Issue 5, Pages 529-537
Publisher
Wiley
Online
2016-04-20
DOI
10.1002/ajh.24370
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The biology and treatment of plasmablastic lymphoma
- (2015) J. J. Castillo et al. BLOOD
- EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment
- (2015) A. Nicolae et al. BLOOD
- Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL
- (2015) F. Offner et al. BLOOD
- Abstract 2673: Idelalisib has activity at clinically achievable drug concentrations in a subset of ABC and GCB diffuse large B-cell lymphoma and transformed follicular lymphoma cell lines
- (2015) Jia Y. Liu et al. CANCER RESEARCH
- Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
- (2015) Grzegorz S. Nowakowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
- (2015) Wyndham H Wilson et al. NATURE MEDICINE
- Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary
- (2015) Chi Young Ok et al. Oncotarget
- Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age
- (2015) Ting-Xun Lu et al. Scientific Reports
- EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
- (2014) J. Y. Hong et al. ANNALS OF ONCOLOGY
- Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
- (2014) Ai Sato et al. CANCER SCIENCE
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries
- (2014) C. Y. Ok et al. CLINICAL CANCER RESEARCH
- Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
- (2014) Umberto Vitolo et al. LANCET ONCOLOGY
- Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy
- (2013) Jae-Sook Ahn et al. AMERICAN JOURNAL OF HEMATOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly
- (2013) C. Y. Ok et al. BLOOD
- Poor Concordance among Nine Immunohistochemistry Classifiers of Cell-of-Origin for Diffuse Large B-Cell Lymphoma: Implications for Therapeutic Strategies
- (2013) R. Coutinho et al. CLINICAL CANCER RESEARCH
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression
- (2012) Ling-Hua Zhang et al. BRITISH JOURNAL OF HAEMATOLOGY
- Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation
- (2012) Vanya Icheva et al. JOURNAL OF CLINICAL ONCOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly is an aggressive post-germinal center B-cell neoplasm characterized by prominent nuclear factor-kB activation
- (2012) Santiago Montes-Moreno et al. MODERN PATHOLOGY
- Epstein-Barr Virus-positive Diffuse Large B-cell Lymphomas of the Elderly
- (2011) Patrick Adam et al. ADVANCES IN ANATOMIC PATHOLOGY
- EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru
- (2011) Brady E. Beltran et al. AMERICAN JOURNAL OF HEMATOLOGY
- Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2011) G. Gutierrez-Garcia et al. BLOOD
- Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents
- (2011) S. K. Ghosh et al. BLOOD
- Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype
- (2011) Francisco J. Hernandez-Ilizaliturri et al. CANCER
- EBV-Positive Diffuse Large B-Cell Lymphoma in Young Immunocompetent Individuals
- (2011) Brady E. Beltran et al. Clinical Lymphoma Myeloma & Leukemia
- Immune defence against EBV and EBV-associated disease
- (2011) Heather M Long et al. CURRENT OPINION IN IMMUNOLOGY
- CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
- (2011) Michael Pfreundschuh et al. LANCET ONCOLOGY
- Geographic variation in the prevalence of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population
- (2011) Annegret Hofscheier et al. MODERN PATHOLOGY
- Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far
- (2011) J. J. Castillo et al. ONCOLOGIST
- Bortezomib Plus CHOP-Rituximab for Previously Untreated Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma
- (2010) Jia Ruan et al. JOURNAL OF CLINICAL ONCOLOGY
- Epstein–Barr virus as a prognostic factor inde novonodal diffuse large B-cell lymphoma
- (2010) Domingo Morales et al. LEUKEMIA & LYMPHOMA
- Critical role of PI3K signaling for NF- B-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells
- (2010) B. Kloo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations
- (2009) Sylvia Hoeller et al. HUMAN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search